Skip to Main content Skip to Navigation
Journal articles

Drug Response Diversity: A Hidden Bacterium?

Abstract : Interindividual heterogeneity in response to treatment is a real public health problem. It is a factor that can be responsible not only for ineffectiveness or fatal toxicity but also for hospitalization due to iatrogenic effects, thus increasing the cost of patient care. Several research teams have been interested in what may be at the origin of these phenomena, particularly at the genetic level and the basal activity of organs dedicated to the inactivation and elimination of drug molecules. Today, a new branch is being set up, explaining the enigmatic part that could not be explained before. Pharmacomicrobiomics attempts to investigate the interactions between bacteria, especially those in the gut, and drug response. In this review, we provide a state of the art on what this field has brought as new information and discuss the challenges that lie ahead to see the real application in clinical practice.
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03280467
Contributor : Isabelle Combe Connect in order to contact the contributor
Submitted on : Wednesday, July 7, 2021 - 1:07:05 PM
Last modification on : Tuesday, October 19, 2021 - 10:50:19 PM

Links full text

Identifiers

Collections

Citation

Nadji Hannachi, Laurence Camoin-Jau. Drug Response Diversity: A Hidden Bacterium?. Journal of Personalized Medicine, MDPI, 2021, 11 (5), pp.345. ⟨10.3390/jpm11050345⟩. ⟨hal-03280467⟩

Share

Metrics

Record views

21